Feasibility of long-term patient self-reporting of toxicities from home via the Internet during routine chemotherapy - Wikidata - awgldk - TriplyDB

Feasibility of long-term patient self-reporting of toxicities from home via the Internet during routine chemotherapy

Feasibility of long-term patient self-reporting of toxicities from home via the Internet during routine chemotherapy

http://www.wikidata.org/entity/Q36977042

about

The level of association between functional performance status measures and patient-reported outcomes in cancer patients: a systematic review PARP inhibitors in the management of breast cancer: current data and future prospects Patient-reported outcomes in routine cancer clinical practice: a scoping review of use, impact on health outcomes, and implementation factors An Association of Cancer Physicians' strategy for improving services and outcomes for cancer patients Integrating patient reported outcomes with clinical cancer registry data: a feasibility study of the electronic Patient-Reported Outcomes From Cancer Survivors (ePOCS) system.Daily collection of self-reporting sleep disturbance data via a smartphone app in breast cancer patients receiving chemotherapy: a feasibility study.Emerging uses of patient generated health data in clinical research.Depression Screening Using Daily Mental-Health Ratings from a Smartphone Application for Breast Cancer Patients Implementation and preliminary effectiveness of a real-time pain management smartphone app for adolescents with cancer: A multicenter pilot clinical study.Electronic patient self-Reporting of Adverse-events: Patient Information and aDvice (eRAPID): a randomised controlled trial in systemic cancer treatment The Potential Role of Symptom Questionnaires in Palliative and Supportive Cancer Care Delivery How to optimize participant retention and complete follow-up in surgical research.Breast Cancer Update 2014 - Focus on the Patient and the Tumour.Feasibility of Conducting a Palliative Care Randomized Controlled Trial in Children With Advanced Cancer: Assessment of the PediQUEST Study Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial.Longitudinal adverse event assessment in oncology clinical trials: the Toxicity over Time (ToxT) analysis of Alliance trials NCCTG N9741 and 979254 Approach to fever assessment in ambulatory cancer patients receiving chemotherapy: a clinical practice guideline.Clinical Relevance of the First Domomedicine Platform Securing Multidrug Chronotherapy Delivery in Metastatic Cancer Patients at Home: The inCASA European Project.Adverse reactions to oncologic drugs: spontaneous reporting and signal detection.An overview of early investigational therapies for chemoresistant ovarian cancer.Implementation and Feasibility of Electronic Patient-Reported Outcome (ePRO) Data Entry in the PRAEGNANT Real-Time Advanced and Metastatic Breast Cancer Registry.Electronic-Based Patient-Reported Outcomes: Willingness, Needs, and Barriers in Adjuvant and Metastatic Breast Cancer Patients.Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials.Training clinicians in how to use patient-reported outcome measures in routine clinical practice.Patient-reported outcomes (PRO) focused on adverse events (PRO-AEs) in adjuvant and metastatic breast cancer: clinical and translational implications.Feasibility of an interactive electronic self-report tool for oral cancer therapy in an outpatient setting.Evaluation of point-of-care PRO assessment in clinic settings: integration, parallel-forms reliability, and patient acceptability of electronic QOL measures during clinic visits.The Imperative for a New Approach to Toxicity Analysis in Oncology Clinical Trials.Integrated care pathways for cancer survivors - a role for patient-reported outcome measures and health informatics.Reliability of an e-PRO Tool of EORTC QLQ-C30 for Measurement of Health-Related Quality of Life in Patients With Breast Cancer: Prospective Randomized Trial.The oncology day hospital in Spain: an updated analysis of Spanish Society of Medical Oncology (SEOM) looking forward.Detection of lung cancer relapse using self-reported symptoms transmitted via an internet web-application: pilot study of the sentinel follow-up.Patient-reported outcomes in cancer care - hearing the patient voice at greater volume.Overview of Patient-Facing Systems in Patient-Reported Outcomes Collection: Focus and Design in Cancer Care.SymptomCare@Home: Developing an Integrated Symptom Monitoring and Management System for Outpatients Receiving Chemotherapy.eRAPID electronic patient self-Reporting of Adverse-events: Patient Information and aDvice: a pilot study protocol in pelvic radiotherapy.

P2860

Q26796534-1C286A0D-7099-4424-AAAC-54E38E951F54 Q26798352-259311D1-9887-4694-8DF4-8DAD5654D129 Q27004014-FB86C0EA-D3FC-4DD6-A6E0-A2B288D5BCA1 Q28603931-C6C98DAE-3DAC-4AF3-8083-48AC38AA2101 Q30684440-D3530946-2A47-4217-8ABA-E0117C3511BD Q30826661-787A13C8-B5C3-430A-8DD0-6FDFE6864E91 Q30854718-CE8C22E6-306D-4455-802C-CAFD8A905D9A Q33450058-DA6F33D6-BB64-4573-A36E-B87BDD7F0E2B Q33454077-4B304BD0-4FDD-4022-9D5A-86A2D393F31F Q33647002-8483ACBC-8F4A-490A-97D3-776FA6B0FB7A Q33900714-8C1F037D-E0DD-46AD-A26B-D0E2AA3003CD Q34576701-391B1008-61F7-4AB3-B9BF-333C77695461 Q35180940-37DB747F-0AC2-444F-978C-194D879239FC Q35934129-96A1FD59-5D69-47B8-A7E1-60DA1C5FCD53 Q36872264-C72E09BA-78D1-4825-83AE-A94165732DCB Q36914459-72E22ABA-5245-43F9-9406-5266CE805BD7 Q37011791-29EBAD99-BAC3-457D-8F82-ED62AD50592C Q37152897-F967423B-190C-4821-8C7C-8AF5D553E41C Q37490938-C055B28A-D23A-4CD8-A793-E1ED8827A5E0 Q38264389-D1D6F2BD-4B0D-4C61-852E-870F4F6C6C27 Q38553247-D12D7541-CD65-4B0C-AD6A-29D2FD036BC8 Q38606464-633B89F3-695C-44A6-80A5-686A37FA5A15 Q38636290-07B41DD7-DD8D-4AE4-80EA-DDB538835AAA Q38957147-751E7B80-E231-4D07-A3C2-238091C6539F Q39058366-60E04CCC-D7A7-43C2-BC64-38B864A7C342 Q39285061-22F89377-7D85-4345-BA93-6CD6D7F6957D Q39879882-16B4A489-AB7A-42BA-BB93-4AFBC71E04AC Q40536183-0D1E0CDA-6C1B-46E0-B933-15243FEF45DF Q40670957-82A4FC47-C4CB-4B48-BACC-A9924460A226 Q41266886-7EB8D922-B88C-4684-B0D8-80761745DBD3 Q42236299-B25E80C5-4B88-432F-B3B3-3098F1837C7C Q42321884-6114D534-52D2-44AF-A1F7-D17C7BC58381 Q45664140-69EE7031-BE3A-4D24-BD5F-8BF1697A2B2C Q47603364-2D907748-8B6F-4841-BFCD-49FFF401E47D Q50068133-EA0EE577-CA22-495B-B5DC-7E82604EE2B5 Q50856632-6146EF9E-A7B7-4C54-BDEF-83F7B396465D Q55491469-A4B094AC-FC45-47D6-A411-1CB5A07D5C9C

P2860

Feasibility of long-term patient self-reporting of toxicities from home via the Internet during routine chemotherapy

http://www.wikidata.org/entity/Q36977042

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Feasibility of long-term patie ...... et during routine chemotherapy

@en

type

label

Feasibility of long-term patie ...... et during routine chemotherapy

@en

prefLabel

Feasibility of long-term patie ...... et during routine chemotherapy

@en

P1433

Q36977042-C8FA0516-EC68-4549-B505-16C32430D834

P1476

Q36977042-CCF778C3-D998-4EEF-8196-7FBBD6BAF329

P2093

Q36977042-05B160EC-F69A-4A73-A77F-A0DA9DA92AF0

Q36977042-0C1A2757-E307-473D-AF30-C78851368B42

Q36977042-0F99F043-D839-41ED-90CE-BE6969688F40

Q36977042-40E7D707-DEB1-4718-B459-F28B0BD2BB42

Q36977042-57D7564E-1EFC-481E-9679-C4D793F42135

Q36977042-593E49C7-CE65-4B38-8713-FCA61E9B13BD

Q36977042-643AA8E2-DB83-4665-AEED-73EDA804DE36

Q36977042-8A862070-0BFF-402A-9223-6E8C995E256C

Q36977042-C3EEB40B-88BE-4D4D-8138-76108B8A3653

Q36977042-C9C5DFB2-609C-424A-9243-D8369FDEA9EC

P2860

Q36977042-002F3448-10E8-4FE8-8EF5-BB8934E92780

Q36977042-0BA80645-211C-475E-B88A-1E9B0C5D2AD4

Q36977042-1E6C20CB-E0E1-47A3-B0E1-0C779FF493EC

Q36977042-239B2A6B-8324-4EEB-A0AC-ABB14BFCD8DD

Q36977042-34DA4AAE-AF52-49C7-ACE9-EE62FC8436FB

Q36977042-3528AC5F-A29B-4A75-881B-F4254B7411A8

Q36977042-366DE486-B7F8-4B61-9EF6-3D8DDA117D92

Q36977042-416E19A6-97B7-4E76-85CB-F29A4CF51D93

Q36977042-42D39CB6-5F43-4967-BC48-3D869E206E68

Q36977042-45C3DFD3-07FD-43D8-8DCB-64EDCA5C890F

P304

Q36977042-DC2769D7-F5AF-462E-95E6-8A7C22E5DF24

P31

Q36977042-D55EE064-23CF-4983-929F-6A71A44863EA

P356

Q36977042-0723F2A6-B0BD-4CAE-8C9D-722A3E416062

P407

Q36977042-AE6F7435-6789-49D4-ACAF-828BB3BD2C12

P433

Q36977042-87442E9C-6188-4C62-B0C2-13C04486814A

P478

Q36977042-C511D6C5-E96E-4CEB-931F-F4F93280ED9B

P50

Q36977042-3343C48A-D8C0-49F1-A212-0A99110A6D56

P577

Q36977042-3DF31CEE-7A28-46C1-980C-39858E50D125

P5875

Q36977042-1CB4EF79-6230-463A-8834-FF827195DD2E

P698

Q36977042-54CAF4FF-C96C-45CB-B172-C3B5B40E573D

P921

Q36977042-3673C02C-2672-436C-ACCD-FE474E9337FC

Q36977042-F0A46111-E193-4F94-A34D-43CA02957169

P932

Q36977042-3613EED5-426C-44DD-B6D8-932FF70E4ED6

P356

JCO.2012.47.6804

P1433

Journal of Clinical Oncology

P1476

Feasibility of long-term patie ...... et during routine chemotherapy

@en

P2093

Allison Barz

http://www.w3.org/2001/XMLSchema#string

Antonia V Bennett

http://www.w3.org/2001/XMLSchema#string

Clifford A Hudis

http://www.w3.org/2001/XMLSchema#string

Deborah Schrag

http://www.w3.org/2001/XMLSchema#string

Howard I Scher

http://www.w3.org/2001/XMLSchema#string

Laura Sit

http://www.w3.org/2001/XMLSchema#string

Lauren J Rogak

http://www.w3.org/2001/XMLSchema#string

Mark G Kris

http://www.w3.org/2001/XMLSchema#string

Paul Sabattini

http://www.w3.org/2001/XMLSchema#string

Timothy J Judson

http://www.w3.org/2001/XMLSchema#string

P2860

Patient-re ported complications and follow-up treatment after radical prostatectomy

Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance

JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis.

A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis.

Feasibility and acceptability to patients of a longitudinal system for evaluating cancer-related symptoms and quality of life: pilot study of an e/Tablet data-collection system in academic oncology.

Tell Us™: a Web-based tool for improving communication among patients, families, and providers in hospice and palliative care through systematic data specification, collection, and use

Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution.

EQ-5D: a measure of health status from the EuroQol Group.

Methodological standards and patient-centeredness in comparative effectiveness research: the PCORI perspective.

The missing voice of patients in drug-safety reporting.

P304

2580-2585

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2012.47.6804

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-06-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

237017881

http://www.w3.org/2001/XMLSchema#string

P698

23733753

http://www.w3.org/2001/XMLSchema#string

P921

P932

3699724

http://www.w3.org/2001/XMLSchema#string